The stock rose from Rs 276 as of May 26, 2023, to Rs 434 on May 26, 2024. The pharma stock hit a record high of Rs 480 on 26th February but the momentum fizzled. It witnessed a steady decline, which took the stock below 50-DMA on the daily charts. After remaining range-bound for the past few months, the stock took support above the broadening Rising Wedge formation in May and bounced back.
The week gone by was highly volatile, with Nifty gaining 2.2% or 490 points in four sessions and hitting a lifetime high of 23,000. The week was also in the news for block deals involving over three dozen companies from large, mid and smallcap segments worth Rs 13,059 crore on screen.